4//SEC Filing
Fishman Mark 4
Accession 0000899243-20-003934
CIK 0001745999other
Filed
Feb 10, 7:00 PM ET
Accepted
Feb 11, 9:06 AM ET
Size
9.3 KB
Accession
0000899243-20-003934
Insider Transaction Report
Form 4
Fishman Mark
Director
Transactions
- Conversion
Common Stock
2020-02-10+17,007→ 17,007 total - Conversion
Series A-1 Preferred Stock
2020-02-10−15,768→ 0 total→ Common Stock (15,768 underlying) - Conversion
Series A-2 Preferred Stock
2020-02-10−1,239→ 0 total→ Common Stock (1,239 underlying)
Footnotes (1)
- [F1]Upon closing of the Issuer's initial public offering, each share of Series A-1 Preferred Stock and Series A-2 Preferred Stock automatically converted into shares of Common Stock without payment or further consideration. There was no expiration date for the Series A-1 Preferred Stock or the Series A-2 Preferred Stock.
Documents
Issuer
Beam Therapeutics Inc.
CIK 0001745999
Entity typeother
Related Parties
1- filerCIK 0001786003
Filing Metadata
- Form type
- 4
- Filed
- Feb 10, 7:00 PM ET
- Accepted
- Feb 11, 9:06 AM ET
- Size
- 9.3 KB